Management is entirely supportive and symptomatic, focusing on maintaining hydration, correcting electrolyte imbalances, and monitoring for complications
The key to success lies in consistent use, healthy lifestyle choices, and patience
Il contribue au diagnostic, au suivi thrapeutique et la lutte contre les grandes endmies (VIH, tuberculose, paludisme) dans la Rgion Centrale du Togo
Days 61 and beyond: Maintain the dose at 7mg/day , or increase to 14mg/day if further glycemic control is required
Knowing how medicines interact helps people stay on track without any preventable setbacks
Its evidence base runs deep: in type-2 diabetes (SUSTAIN1) semaglutide cut HbA1c by 1.55 points[2], and in the 17,604-patient SELECT cardiovascular trial it reduced major cardiac events by 20% in adults with obesity and no diabetes[3]